文献速递生殖医学

DEFB126变异在男性不育及辅助生殖技术结局中的作用

The role of DEFB126 variation in male infertility and medically assisted reproduction technique outcome.
PubMed 文献 · Reprod Biomed Online · 2019-05-21

研究在277例伊朗不明原因不育男性和100例生育力正常对照中检测DEFB126的2-nt缺失及其蛋白表达,缺失在不育患者中显著更高(P ≤ 0.05);缺失导致IUI后临床妊娠率显著降低(P ≤ 0.05),但IVF/ICSI结局按基因型无差异;del/del男性蛋白表达显著低于其他基因型。

要点

  • DEFB126的2-nt缺失在不育患者中显著高于对照(P ≤ 0.05)。
  • 该缺失与IUI后临床妊娠率显著降低相关(P ≤ 0.05)。
  • IVF/ICSI结局按基因型无差异;del/del男性精液常规正常但精子功能受损。

核心结论

  • DEFB126序列变异可能损害男性生殖功能并与男性不育相关。
  • del/del基因型男性精液常规正常但精子功能明显受损,可影响IUI治疗结局而不影响IVF/ICSI治疗。

研究设计与样本

  • 采用标准聚合酶链反应(PCR)测序和免疫细胞化学分别检测DEFB126的2-nt缺失及其在精子中的蛋白表达。
  • 纳入277例伊朗不明原因不育男性,其中139例接受宫腔内人工授精(IUI)、103例接受IVF/卵胞浆内单精子注射(ICSI),35例拒绝任何辅助生殖治疗;另纳入100例精液常规正常的生育力正常男性作为对照。
  • 根据临床妊娠率评估辅助生殖技术结局。

主要发现

  • DEFB126的2-nt缺失在不育患者中显著高于对照(P ≤ 0.05)。
  • 该缺失导致IUI后临床妊娠率显著降低(P ≤ 0.05)。
  • IVF/ICSI结局按基因型无差异。
  • del/del男性蛋白表达显著低于其他基因型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Human DEFB126 is an important component of the glycocalyx of human spermatozoa. Beta-defensins play a primary role in male infertility due to their involvement in maturation and capacitation of spermatozoa. A 2-nt deletion of DEFB126 affects sperm function and so this study investigated the possible association between DEFB126 variants and its protein expression on medically assisted reproduction (MAR) technique outcome in Iranian infertile males. DESIGN: The presence of a 2-nt deletion of DEFB126, and its protein expression in spermatozoa, were investigated by standard polymerase chain reaction (PCR) sequencing and immunocytochemistry, respectively. MAR technique outcome according to clinical pregnancy rates was assessed in 277 Iranian males with unexplained infertility, including 139 patients who underwent intrauterine insemination (IUI) and 103 patients who underwent IVF/intracytoplasmic sperm injection (ICSI), as well as 35 infertile males who declined to use any MAR treatment. As the control group, 100 fertile males with a normal spermiogram were enrolled. RESULTS: The 2-nt deletion of DEFB126 was significantly higher in infertile patients than controls (P ≤ 0.05). The presence of this deletion resulted in significantly lower clinical pregnancy rates following IUI (P ≤ 0.05); however, there were no differences in IVF/ICSI outcomes according to genotype. The protein expression in del/del males was also remarkably lower than that of the other genotypes. CONCLUSIONS: This sequence variation of DEFB126 may impair male reproductive function and can be related to male infertility. Interestingly, males with the del/del genotype have a normal spermiogram; however, their spermatozoa are evidently functionally impaired, which can affect IUI treatment outcome, but not treatment by IVF/ICSI.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Boroujeni PB, Ebrahimian S, Abedini M, et al. The role of DEFB126 variation in male infertility and medically assisted reproduction technique outcome. Reprod Biomed Online. 2019. PMID: 31474436. doi:10.1016/j.rbmo.2019.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。